FINDING AND ROLE OF HEPATITIS C VIRUS IN THE PATHOGENESIS OF HODGKIN LYMPHOMA PATIENTS: A STUDY AT COMBINED MILITARY HOSPITAL PESHAWAR

Authors

  • Sayyeda Aisha Bahar
  • Aqsa Amjad
  • Sana Arshad
  • Alina
  • Fazal Rabi
  • Kamran Saeed
  • Junaid Farman

DOI:

https://doi.org/10.53555/jptcp.v31i5.7036

Keywords:

HCV, Hodgkin Lymphoma, pathogenesis, prevalence

Abstract

Background:  Hodgkin Lymphoma (HL) is a cancer of the lymphatic system; however, its cause is still unknown to date. Newer studies indicate that Hepatitis C Virus (HCV) may play a role in HL development.

Objectives:  The study aims are as follows: To establish the incidence of HCV in HL patients and examine its involvement in HL advancement.

Study design: A cross-sectional study.

Place and duration of study. Combined Military Hospital Peshawar from 05-Jan 2023 to 05-Jan 2024.

Methods:  Consequently, this study was cross-sectional, for which we recruited 200 patients with HL at CMH Peshawar. Information on HCV status included self-reports from patients’ medical records and blood tests. Data analysis was done using SPSS 24. 0 to analyze the HCV and HL relationship.

Results:  Among the 200 patients (mean age: The study participants’ mean age was 45 years with a standard deviation of 12 years; 20% of the participants were HCV positive. Results of the analysis of data revealed that there was a moderate relationship between HCV infection and HL at the P = 0. 03 level of significance.

Conclusion:  Based on this study, HCV infection has a significant positive relationship with HL and may therefore be involved in HL development. Preventive measures include the recommendation of routine hepatitis C virus screening in HL patients to enhance identification and treatment.

Author Biographies

  • Sayyeda Aisha Bahar

    Female Medical Officer, DHQ, Mishti Mela, Orakzai, KPK

  • Aqsa Amjad

    TMO Medicine Combined Military Hospital Peshawar, KPK

  • Sana Arshad

    TMO Medicine Khyber Teaching Hospital, Peshawar, KPK

  • Alina

    TMO Medicine Khyber Teaching Hospital, Peshawar, KPK

  • Fazal Rabi

    Medical Specialist DHQ, Mishti Mela, Orakzai, KPK

  • Kamran Saeed

    TMO Medicine Ayub Teaching Hospital, Abbottabad, KPK

  • Junaid Farman

    TMO Orthopedics Ayub Teaching Hospital, Abbottabad, KPK

References

Young KH, Lee JY, Kim H, et al. (2006). Hepatitis C virus and lymphoproliferative disorders. World J Gastroenterol. 12(35):5635-5639.

Zignego AL, Ferri C, Giannelli F, et al. (2007). Prevalence of bcl-2 rearrangement in patients with chronic hepatitis C virus infection and lymphoproliferative disorders. Hepatology. 46(4):1030-1034.

Pileri SA, Uematsu Y, Campagnoli MF, et al. (1994). Binding of hepatitis C virus to CD81. Science. 282(5390):938-941.

Waheed Y, Shafi T, Safi SZ, et al. (2009). Hepatitis C virus in Pakistan: a systematic review of prevalence, genotypes and risk factors. World J Gastroenterol. 15(45):5647-5653.

Idrees M, Riazuddin S. (2008). Frequency distribution of hepatitis C virus genotypes in different geographical regions of Pakistan and their possible routes of transmission. BMC Infect Dis. 8:69.

Montella M, Crispo A, Russo F, et al. (2004). HCV and risk of lymphomas: a case-control study. Br J Cancer. 90(3):341-344.

Montella M, Crispo A, Russo F, et al. (2004). HCV and risk of lymphomas: a case-control study. Br J Cancer. 90(3):341-344.

De Sanjose S, Benavente Y, Vajdic CM, et al. (2008). Hepatitis C and non-Hodgkin lymphoma among 4784 cases and 6269 controls from the International Lymphoma Epidemiology Consortium. Clin Gastroenterol Hepatol. 6(4):451-458.

Zuckerman E, Zuckerman T, Levine AM, et al. (1997). Hepatitis C virus infection in patients with B-cell non-Hodgkin lymphoma. Ann Intern Med. 127(6):423-428.

Pozzato G, Mazzaro C, Crovatto M, et al. (1994). Low-grade malignant lymphoma, hepatitis C virus infection, and mixed cryoglobulinemia. Blood. 84(9):3047-3053.

Dal Maso L, Polesel J, Serraino D, et al. (2009). Hepatitis C virus and risk of lymphomas: results of the multi-center Italian study. Int J Cancer. 124(8):1881-1886.

Vassilopoulos D, Calabrese LH. (2005). Hepatitis C virus infection and lymphoproliferative disorders: more than just an association? Cleve Clin J Med. 72(10):1055-1065.

Hermine O, Lefrere F, Bronowicki JP, et al. (2002). Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection. N Engl J Med. 347(2):89-94.

Lakhani MS, Quraishy MS, Khokhar N, et al. (2005). Treatment of hepatitis C virus infection: a review. Trop Gastroenterol. 26(3):117-125.

Engert A, Eichenauer DA, Dreyling M; ESMO Guidelines Working Group. (2010). Hodgkin’s lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 21 Suppl 5

Ferenci P. (2007). Hepatitis C and lymphoma. J Clin Gastroenterol. 41(7):701-702.

Muhammad K, Ayub S, Haider I, et al. (2011). Hepatitis C virus-related chronic hepatitis in Pakistan: a study of HCV genotypes. J Gastroenterol Hepatol. 26(4):662-666.

Downloads

Published

2024-05-25

How to Cite

Sayyeda Aisha Bahar, Aqsa Amjad, Sana Arshad, Alina, Fazal Rabi, Kamran Saeed, & Junaid Farman. (2024). FINDING AND ROLE OF HEPATITIS C VIRUS IN THE PATHOGENESIS OF HODGKIN LYMPHOMA PATIENTS: A STUDY AT COMBINED MILITARY HOSPITAL PESHAWAR. Journal of Population Therapeutics and Clinical Pharmacology, 31(5), 1986-1991. https://doi.org/10.53555/jptcp.v31i5.7036
More Citation Formats

Issue

Section

Articles

How to Cite

Sayyeda Aisha Bahar, Aqsa Amjad, Sana Arshad, Alina, Fazal Rabi, Kamran Saeed, & Junaid Farman. (2024). FINDING AND ROLE OF HEPATITIS C VIRUS IN THE PATHOGENESIS OF HODGKIN LYMPHOMA PATIENTS: A STUDY AT COMBINED MILITARY HOSPITAL PESHAWAR. Journal of Population Therapeutics and Clinical Pharmacology, 31(5), 1986-1991. https://doi.org/10.53555/jptcp.v31i5.7036

Most read articles by the same author(s)